Table 1.
Baseline characteristics of each group
| Experimental group (n = 20) | Control group (n = 20) | p value | |
|---|---|---|---|
| Age (yr) | 61.70 ± 5.95 | 61.00 ± 5.65 | 0.705 |
| Sex (male/female) | 12/8 | 9/11 | 0.342 |
| Left/right side | 5/6 9 bilat | 4/5 11 bilat | 0.527 |
| Body weight (kg) | 64.06 ± 7.12 | 64.95 ± 6.81 | 0.453 |
| Duration of symptoms (day) | 5.90 ± 1.07 | 6.35 ± 1.46 | 0.274 |
| Risk factors | |||
| Previous DVT | 14 | 15 | 0.723 |
| Malignancy | 1 | 2 | 0.99 |
| Others | 5 | 3 | 0.695 |
| MAP (mmHg) | 58.55 ± 7.72 | 61.8 ± 5.28 | 0.128 |
| CVP (mmHg) | 15.30 ± 2.13 | 15.55 ± 2.42 | 0.73 |
| PaO2/FIO2 | 132.75 ± 19.95 | 128.75 ± 15.91 | 0.488 |
| RVEF | 43.90 ± 4.22 | 43.65 ± 4.00 | 0.849 |
| PASP (mmHg) | 58.05 ± 6.33 | 58.30 ± 1.57 | 0.906 |
MAP: mean arterial pressure; CVP: central venous pressure; PaO2/FiO2: oxygenation index; RVEF: right ventricular ejection fraction; PASP: pulmonary artery systolic pressure.